X4 Pharmaceuticals closes $80 million term loan

X4 Pharmaceuticals said it entered a loan and security agreement providing for up to $150 million in term loans, including an $80 million first tranche funded on the closing date. The company said it used part of the proceeds to repay its Hercules loan and will use the rest for working capital and general corporate purposes.